On Monday, embattled drugmaker Mylan NV (MYL – Analyst Report) announced that it will launch a generic version of the EpiPen at a 50% discount to the branded version as the company continues to respond to widespread criticism surrounding the
Consider These Aspects Of Large Outdoor Water Fountain While Buying Them
U.S. Cereal Company, Post Holdings Inc., Buying Weetabix Ltd. For $1.8 Billion
USD/JPY Making A Bullish N Pattern Through Chuvashov Fork
Fast Fashion Has Changed The Industry And The Economy
Leadership Report Card: Why Most Managers Don’t Get an ‘A’
